Skip to main content
. 2020 Jun 12;20(1):53–65. doi: 10.3727/105221620X15880179864121

Table 1.

Summary of Known Resistance Mechanisms to Checkpoint Inhibitors

Categories of Resistance Mechanism of Resistance
Tumor intrinsic factors Downregulation of antigen processing and presentation: HLA deletion144,145, β2 microglobulin146
Downregulation of cytokines and signaling pathways: loss of JAK1/2 function69,147, deletion of interferon IFNGR1/2, IRF1 148
β-Catenin activation (due to mutations in CTNNB1 gene)73
Tumor extrinsic factors TILs exclusion by PTEN deletion and VEGF upregulation149
Expression of alternative coinhibitory checkpoint receptors like TIM-3, LAG-3, TIGIT, VISTA, and BTLA69,126
Decreased TILs to Treg ratio150–152
Downregulation of dendritic cell recruitment through β-catenin signaling110
Increased immunosuppressive cells such as MDSCs, Tregs151,153,154
Epithelial-to-mesenchymal transition155
Microbiome75, 143